Advanced search
Publication Cover
Drug, Healthcare and Patient Safety Volume 2, 2010 - Issue
Submit an article Journal homepage
89
Views
5
CrossRef citations to date
0
Altmetric
Review

Dipeptidyl peptidase-4 inhibitors in the management of type 2 diabetes: safety, tolerability, and efficacy

Mary Elizabeth Cox1 Department of Medicine, Division of Endocrinology, Metabolism, and Nutrition. Duke University Medical Center, Durham, NC, USA
,
Jennifer Rowell1 Department of Medicine, Division of Endocrinology, Metabolism, and Nutrition. Duke University Medical Center, Durham, NC, USA
,
Leonor Corsino1 Department of Medicine, Division of Endocrinology, Metabolism, and Nutrition. Duke University Medical Center, Durham, NC, USA
&
Jennifer B Green1 Department of Medicine, Division of Endocrinology, Metabolism, and Nutrition. Duke University Medical Center, Durham, NC, USA;2 Department of Medicine, Division of Endocrinology, Durham Veterans Affairs Medical Center, Durham, NC, USACorrespondence[email protected]
Pages 7-19 | Published online: 28 Jan 2010

Citations (5)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Daisuke Yabe & Yutaka Seino. (2016) Alogliptin for the treatment of type 2 diabetes: a drug safety evaluation. Expert Opinion on Drug Safety 15:2, pages 249-264.
Read now
Yutaka Seino & Daisuke Yabe. (2014) Alogliptin for the treatment of Type 2 diabetes. Expert Review of Endocrinology & Metabolism 9:6, pages 547-559.
Read now
Kohei Kaku, Mikiko Mori, Tatsuhiro Kanoo, Masafumi Katou & Yutaka Seino. (2014) Efficacy and safety of alogliptin added to insulin in Japanese patients with type 2 diabetes: a randomized, double-blind, 12-week, placebo-controlled trial followed by an open-label, long-term extension phase. Expert Opinion on Pharmacotherapy 15:15, pages 2121-2130.
Read now
Yutaka Seino & Daisuke Yabe. (2014) Alogliptin benzoate for the treatment of type 2 diabetes. Expert Opinion on Pharmacotherapy 15:6, pages 851-863.
Read now
Hans-Juergen Woerle & Sanjay Patel. (2010) Incorrect description of mode of excretion of linagliptin. Drug, Healthcare and Patient Safety 2, pages 93-93.
Read now

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.